DOI: 10.1128/AAC.01830-17
Article Information
PubMed
Published By
History
- Received September 6, 2017
- Returned for modification October 4, 2017
- Accepted November 21, 2017
- Published online January 25, 2018.
Copyright & Usage
Copyright © 2018 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (November 27, 2017).
- You are viewing the most recent version of this article.
Author Information
- Gaofei Lua*,
- Gregory R. Bluemlinga,b,
- Shuli Maoa,
- Michael Hagera,
- Bharat P. Guralea,
- Paul Collopa,
- Damien Kuipera,
- Kasinath Sanaa*,
- George R. Paintera,b,c,
- Abel De La Rosaa,b and
- Alexander A. Kolykhalova,b
- aEmory Institute for Drug Development (EIDD), Emory University, Atlanta, Georgia, USA
- bDrug Innovation Ventures at Emory (DRIVE), Atlanta, Georgia, USA
- cDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA
- Address correspondence to Alexander A. Kolykhalov, a.kolykhalov{at}emory.edu.
↵* Present address: Gaofei Lu, Global Health Drug Discovery Institute (GHDDI), Beijing, China; Kasinath Sana, E. I. DuPont India Pvt. Ltd., Dupont Knowledge Center, Hyderabad, India.
Citation Lu G, Bluemling GR, Mao S, Hager M, Gurale BP, Collop P, Kuiper D, Sana K, Painter GR, De La Rosa A, Kolykhalov AA. 2018. Simple in vitro assay to evaluate the incorporation efficiency of ribonucleotide analog 5′-triphosphates into RNA by human mitochondrial DNA-dependent RNA polymerase. Antimicrob Agents Chemother 62:e01830-17. https://doi.org/10.1128/AAC.01830-17.
